• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Get Email Updates
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Get Email Updates
  • We’re hiring!

Riboscience — COVID-19 Drug Research

Visit Grantee Site
  • Portfolio Area: Science Supporting Biosecurity and Pandemic Preparedness
  • Focus Area: Scientific Research
  • Organization Name: Riboscience
  • Amount: $210,000

  • Award Date: September 2020

Table of Contents


    Grant investigators: Chris Somerville and Heather Youngs

    This page was reviewed but not written by the grant investigators. Riboscience staff also reviewed this page prior to publication.


    Open Philanthropy recommended an investment of $210,000 in Riboscience to support work to test a new drug candidate against COVID-19.

    This falls within our work on scientific research, specifically within our interest in advancing science supporting biosecurity and pandemic preparedness.

    Related Items

    • Science Supporting Biosecurity and Pandemic Preparedness

      Binx — COVID-19 Testing Platform

      Open Philanthropy recommended an investment of $2,000,000 in Binx to support work to incorporate Sherlock Biosciences’s COVID-19 assay into Binx's point-of-care diagnostic platform. This funding is intended to...

      Read more
    • Science Supporting Biosecurity and Pandemic Preparedness

      Icosavax — COVID-19 Vaccine Development

      Open Philanthropy recommended an investment of $6,500,000 in Icosavax to support the development of their virus-like-particle vaccine platform, including a new COVID-19 vaccine. Compared with other vaccines in...

      Read more
    • Science Supporting Biosecurity and Pandemic Preparedness

      Sherlock Biosciences — Research on Viral Diagnostics

      The Open Philanthropy Project recommended a grant of up to $17,500,000 over five years and an additional investment in Sherlock Biosciences to support the development of a diagnostic...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    Sign Up to Follow Our Work

    Join Our Mailing List

    © Open Philanthropy 2022